ALGN

ALIGN TECHNOLOGY INC

ALGN·016255101·US·Common Stock·Healthcare - Medical Instruments & Supplies-13D/G

ALGN (ALIGN TECHNOLOGY INC) is held by 255 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($745.4M), VANGUARD CAPITAL MANAGEMENT LLC ($742.3M), FMR LLC ($684.8M). Net institutional sentiment: Mixed. In Q2 2026, 2 members of Congress and 123 funds bought ALGN.

255
Holders
(19 Elite)
$10.9B
Total Value
47% (261)
Consensus
123 buying - 138 selling
13F: Insider & Congress: Updated regularly
ALGN

Smart Money Verdict

View all
Loading verdict
Held by 255 funds
19 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Feb 20, 2026 · Activists Aug 12, 2026 · Congress Oct 22, 2025

ActivistCapital World InvestorsCapital World Investors5.0%Aug 12, 2026
ActivistGZG. Zachary Gund, as trustee, sole manager or co-manager2.6%Aug 12, 2026
InsiderMJMorici JohnSell $1.5MFeb 18, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
4.4M(+3.0%)$745.4M0.0%-24.00%
33
Increased
4.4M(+0.3%)$742.3M0.0%-8.07%
32
Increased
4.1M(+50.4%)$684.8M0.0%-10.13%
44
Increased
4M(+6.2%)$682.3M0.1%-0.75%
40
Decreased
3.4M(-16.0%)$577.2M0.1%-23.34%
0
Increased
3.4M(+87.8%)$568.8M0.0%-9.70%
49
Decreased
3.1M(-0.6%)$528.2M0.0%-8.08%
0
Increased
2.6M(+1.7%)$431.5M0.0%-42.01%
32
Increased
2.2M(+25.4%)$378.2M0.0%-37.00%
38
Decreased
2.2M(-0.8%)$372.7M0.8%-13.40%
0
Increased
2.1M(+51.3%)$358.5M0.0%-7.84%
43
Decreased
1.7M(-8.9%)$292.4M0.9%-18.40%
0
Increased
1.4M(+48.0%)$242.7M0.0%-15.34%
42
Increased
1.4M(+7.7%)$238.4M0.0%-39.99%
33
Increased
1.1M(+1.6%)$180.7M0.1%+3.76%
31
Increased
1.1M(+3.6%)$180.3M0.6%-20.43%
45
Increased
1M(+0.1%)$171M0.0%-26.39%
30
Increased
899,731(+0.7%)$151.2M0.1%-8.38%
30
Increased
773,182(+1.6%)$134.7M0.0%-8.22%
31
Increased
668,129(+3.8%)$112.7M0.0%-26.79%
31

Showing 1-20 of 274

1 / 14
ALGNALGNALIGN TECHNOLOGY INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used